About Kaiser Immune Deficiency Clinic of Portland CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kaiser Immune Deficiency Clinic of Portland CRS
During the past decade, Kaiser Immune Deficiency Clinic of Portland CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
2013-12-02
2034-02-05
Active, not recruiting
1,087
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
2014-03-29
2028-10-28
Active, not recruiting
608
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
2014-06-16
2022-04-15
Completed
1,864
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Immune Deficiency Clinic of Portland CRS"
#1 collaborator was "Chiron Corporation" with 1 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kaiser Immune Deficiency Clinic of Portland CRS
According to Clinical.Site data, the most researched conditions in "Kaiser Immune Deficiency Clinic of Portland CRS" are
"HIV Infections" (7 trials), "Anus Neoplasms" (1 trials) and "Human Immunodeficiency Virus" (1 trials). Many other conditions were trialed in "Kaiser Immune Deficiency Clinic of Portland CRS" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Immune Deficiency Clinic of Portland CRS
Most popular intervention types in "Kaiser Immune Deficiency Clinic of Portland CRS" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Continuous ART" (1 trials), "Delayed ART" (1 trials), "Maraviroc along with an optimized background antiretroviral drug regimen" (1 trials), "Optimized background antiretroviral drug regimen without maraviroc" (1 trials) and "Recombinant interleukin-2 (rIL-2)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Immune Deficiency Clinic of Portland CRS
The vast majority of trials in "Kaiser Immune Deficiency Clinic of Portland CRS" are
8 trials for "All" genders.
Clinical Trials Status at Kaiser Immune Deficiency Clinic of Portland CRS
Currently, there are NaN active trials in "Kaiser Immune Deficiency Clinic of Portland CRS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Kaiser Immune Deficiency Clinic of Portland CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Immune Deficiency Clinic of Portland CRS, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".